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ABSTRACT | A 45-year-old man presented with a 3-month 
history of a mass located in the caruncle of his right eye. An 
incisional biopsy had been performed one month prior by 
another specialist, and the histopathology report showed 
basal cell carcinoma. The mass was completely excised with 
a 2 mm safety margin, and the large conjunctival defect was 
reconstructed with one sheet of amniotic membrane allograft. 
A histological diagnosis of pilomatrix carcinoma was established. 
To prevent recurrence after surgery, we added bevacizumab 
(25 mg/mL, 1.25 mg/mL per drop) eye drops four times per day 
for three months. At the one-year follow-up, the patient showed 
no evidence of local recurrence or distant metastasis after 
initial excision and remains under close follow-up. Pilomatrix 
carcinoma should be considered in the differential diagnosis 
of a caruncular mass.
Keywords: Hair follicle; Hair diseases; Skin neoplasms; Pilo-
matrixoma; Carcinoma, basal cell; Lacrimal apparatus diseases; 
Bevacizumab/administration & dosage; Diagnosis, Differential; 
Humans
RESUMO | Um homem de 45 anos apresentou história de massa 
na carúncula no olho direito durante 3 meses. Uma biópsia 
incisional foi realizada 1 mês antes por outro especialista e o 
laudo histopatológico mostrava carcinoma basocelular. A massa 
foi completamente excisada, com uma margem de segurança de 
2 mm, e a grande lesão conjuntival foi reconstruída com uma 
folha de aloenxerto de membrana amniótica. Foi estabelecido 
um diagnóstico histológico de carcinoma pilomatricial. Para 
evitar a recorrência após a cirurgia, adicionamos colírio de 
bevacizumabe (25 mg/mL, 1,25 mg/mL por gota) quatro vezes 
ao dia durante três meses. No seguimento de 1 ano, o paciente 
não apresentou evidência de recidiva local ou metástase distante 
após a excisão inicial e continua sob acompanhamento próximo. 
O carcinoma pilomatricial deve ser considerado no diagnóstico 
diferencial de uma massa caruncular.
Descritores: Folículo piloso; Doenças do cabelo; Neoplasias 
cutâneas; Pilomatrixoma; Carcinoma basocelular; Doenças do 
aparelho lacrimal; Bevacizumab/administração & dosagem; 
Diagnóstico diferencial; Humanos
INTRODUCTION
Pilomatricoma is a rare, benign, slow-growing dermal 
or subcutaneous tumor that occurs most commonly in 
the head, neck, extremities, and trunk(1). In 1949, Lever 
and Griesemer(2) proposed that this tumor originates 
from hair matrix cells. In 1961, Forbis and Helwig(3) 
pro posed the currently accepted name of “pilomatri-
coma”. In 1980, Lopansri and Mihm(4) identified ma-
lignant trans formations in these tumor cells, and they 
described these transformations as “pilomatrix car-
cinoma” (PMC) or “calcifying epitheliocarcinoma of 
Malherbe.” In the present report, we describe the 
clinical and histological features in a very rare case of 
malignant hair follicle tumor involving the conjunctiva. 
To the best of our knowledge, this is the first report on 
the PMC of the ocular surface.
CASE REPORT
A 45-year-old man presented with a nontender en-
larged mass measuring approximately 15 mm × 15 mm 
that had grown from the lacrimal caruncle of the right 
eye for more than three months (Figure 1A). He did not 
complain of pain or discharge from the mass. An inci-
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sional biopsy had been performed one month prior by 
another specialist; the histopathology report showed the 
presence of basal cell carcinoma. The patient had no 
notable ophthalmic or medical history. During ocular 
examination, visual acuity in both eyes was 10/10 (de-
cimal scale), and extraocular movements were normal. 
The surface of the pinkish mass was smooth without 
visible vessels, and the well-demarcated lesion was not 
connected to the surrounding skin. No other lesions 
were present on the eyelid. The results of the ante-
rior and posterior ocular examinations were normal. 
Moreover, the patient’s general physical examination 
results were normal, and there was no evidence of 
preauricular or submandibular lymphadenopathy. The 
patient underwent surgical excision and topical che-
motherapy. Under general anesthesia, the mass and a 
2 mm safety margin were completely excised and sent 
for histopathological examination. Double freeze-thaw 
cryotherapy was applied to the conjunctival borders and 
the base of the mass. The large conjunctival defect was 
reconstructed with one sheet of amniotic membrane 
allograft secured with polyglactin sutures. Histopatho-
logical examinations revealed the subepithelial irregular 
infiltration of basaloid cells with hyperchromatic, ovoid, 
and vesicular nuclei, as well as limited cytoplasm in a 
trabecular or nested pattern (Figure 2A). Some nests of 
the basaloid cells showed central keratinization (Figure 
2B). In some areas, enucleated “ghost” or “shadow” cells 
were present with eosinophilic cytoplasm. These cells 
appeared to have merged with basaloid cell groups 
(Figures 2B and 2C). Focal giant cell reactions were de-
tected, and no calcification was present. The invasion 
of the surrounding tissue was observed in desmoplastic 
stroma (Figure 2D). There were no retraction artifacts 
between the basaloid cells and stroma. Mitoses were 
frequently observed (average 20-25 per 10 high-power 
fields in basaloid areas). No definite vascular or lympha-
tic permeations were identified. The Ki67 proliferation 
index was 80%. Immunohistochemical analysis showed 
diffuse positive reactions for Ber-EP4; however, there 
were no positive reactions for EMA, p63, S100, CD56, 
or CK20. A diagnosis of PMC was made on the basis of 
patient age, tumor localization, and histomorphological 
findings. The surgical margins were free of tumor cells. 
The results of complete blood cell count, renal and liver 
function tests, chest x-ray, and neck and abdomen ultra-
sound investigations were normal. The patient provided 
informed consent for further treatment; thus, we admi-
nistered bevacizumab (25 mg/mL, 1.25 mg/mL per drop) 
eye drops four times per day for three months to prevent 
recurrence after surgery. At the one-year follow-up after 
initial excision, the patient showed no evidence of local 
recurrence or distant metastasis. The patient continues 
to be closely monitored (Figures 1B and 1C).
DISCUSSION
The most common sites for PMCs are the head and 
neck, followed by the upper extremities, trunk, and lower 
extremities(5). In a review by Sia et al.(6), 6 cases were 
reported to be PMCs among the 16 cases involving hair 
follicle malignancies in the periorbital region. In that re-
view, the upper lid was the most commonly affected 
site by malignant hair follicle tumors, followed by the 
lower lid, eyebrow, and medial canthal region. The lacri-
mal caruncle has a nonkeratinized epithelial lining that 
is similar to the conjunctival epithelium(7). Developmen-
tally, it constitutes a part of the lower lid; therefore, it 
contains hair follicles, sebaceous glands, and sweat glands. 
A B C
Figure 1. A) Clinical appearance of nonpigmented solid neoplasm involving 
the medial area of the epibulbar conjunctiva, plica, and caruncle of the 
right eye. B) Satisfactory cosmetic and functional results at eight weeks 
after tumor excision and amniotic membrane transplantation. C) No sign 
of local recurrence at one year after surgery; mild fibrosis is present in 
the transplanted area.
A
C
B
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Figure 2. A) Tumor infiltration is present beneath the conjunctiva epithelium 
(arrow) (H&E, ×40). B) Two types of tumor cells (basaloid [thin arrow] and 
ghost [thick arrow] cells) can be observed, along with focal keratinization 
(arrowhead) (H&E, ×400). C) Ghost cells and mitotically active basaloid 
cells in PMC (H&E, ×400). D) Irregular infiltration of the tumor is present 
in the desmoplastic stroma (H&E, ×100).
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It also harbors accessory lacrimal tissue. Hence, neo-
plasms that may arise from the skin, conjunctiva, and 
lacrimal gland may develop in the lacrimal caruncle(7). 
None of the cases identified in the PubMed database 
reported on the primary hair follicle tumor of the lacri-
mal caruncle.
Conjunctival involvement is not a typical finding in 
hair follicle malignancies. Lee et al.(8) reported a case 
of trichilemmal carcinoma of the upper eyelid in a 
51-year-old man. They reported that the mass com-
pletely penetrated the inner side of the upper lid and 
was present on the conjunctival side during slit-lamp 
examination. To the best of our knowledge, the present 
report is the first description of the PMC of the ocular 
surface involving the conjunctiva. In our case, PMC was 
originally misdiagnosed as basal cell carcinoma after 
incisional biopsy; it was later diagnosed as PMC on the 
basis of the excised specimen. This misdiagnosis was 
caused by the lack of clear histologic criteria and the 
lack of a specific marker to distinguish this neoplasm 
from other matrical tumors (5).
Histopathologically, PMCs can be distinguished from 
benign pilomatricoma, trichoblastic carcinoma, and 
basal cell carcinoma owing to matrical differentiation. 
Basal cell carcinoma presents with infiltrating islands 
of palisading basaloid cells with shadow cells. Histo-
logical examination can be challenging, and malignant 
pilomatricoma with many basophilic basal cells is often 
mistaken for basal cell carcinoma(9). Differentiation is 
dependent upon the observation of retraction spaces 
between neoplastic cells and stroma(5,9). In the present 
case, there were no retraction artifacts between basaloid 
cells and stroma. Furthermore, proliferating pilomatri-
coma, which is a pathological variant of pilomatricoma 
that consists predominantly of mitotically active basa-
loid cells, should be included in the differential diagnosis. 
In such cases, poor circumscription, an asymmetrical 
appearance, atypical mitoses, and lymphovascular inva-
sion are features that favor a diagnosis of PMC(10).
PMC can exhibit local aggressive behavior with a ten-
dency toward recurrence. Thus, we administered topical 
chemotherapy to prevent recurrence even though the 
surgical margins were free of tumor cells. To the best of 
our knowledge, this is the first reported case of PMC of 
the ocular surface; therefore, there is no standard topical 
chemotherapy protocol for similar cases. It has recently 
been reported that topical bevacizumab may reduce tumor 
size prior to surgery or may completely cure the tumor 
in ocular surface squamous neoplasia(11,12). Additionally, 
the systemic application of bevacizumab is a treatment 
option in PMC when local recurrence and distant me-
tastasis are detected(13). Although the use of topical 
bevacizumab as an adjuvant therapy after the surgical 
treatment of ocular surface neoplasms is not a proven 
treatment option, it is regarded a good and safe option 
on the basis of the literature described above. We have 
not observed any side effects after three months of con-
tinuous treatment with topical bevacizumab.
Local recurrences and metastatic disease have been 
documented after the simple excision of these types of 
lesions(6). Therefore, the creation of a sufficiently wide 
excision with a tumor-free margin is important during 
histopathological examination. In our case, after consi-
dering the clinical appearance of surgical margins and 
the results of the previous biopsy, we concluded that 
the resection of the tumor with a 2 mm margin of safety 
would ensure its complete removal. A wider excision 
could have been made after pathological examination, 
but there was a high risk of inadvertently damaging 
the canalicular system because of the proximity of the 
primary lesion to this system. Furthermore, the patient 
would have been required to undergo general anesthesia 
because he could not tolerate surgery under local anes-
thesia, and it would have been more difficult to make 
precise excisions because the tumor margin would be 
obscured following two previous surgeries in the same 
area. The patient was informed of the current situation 
and decided not to undergo a second surgical procedure. 
Consequently, a second surgery was not performed. 
Topical chemotherapy was initiated, and the patient 
underwent continuous monitoring.
This case highlights the rare potential for conjunctival 
lesions to have unusual origins with potentially serious 
consequences. To make accurate excisions during the ini-
tial surgery, frozen section examinations should be per-
formed during surgery, and differential diagnosis should 
be made with the inclusion of conditions such as PMC.
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